Literature DB >> 9706183

Grapefruit juice and the response to warfarin.

D M Sullivan1, M A Ford, T W Boyden.   

Abstract

The effect if any of prepared frozen grapefruit juice on prothrombin times (PTs) in patients undergoing stabilized warfarin therapy was studied. Patients receiving low-intensity warfarin therapy (targeted International Normalized Ratio [INR], 2-3) who had two consecutive baseline PTs within 10% of each other were recruited. Patients who regularly consumed grapefruit juice or alcohol or who were taking drugs known to interact with grapefruit juice were excluded. A one-week supply of freshly prepared frozen grapefruit juice in individual 8-oz containers was given to all the subjects, who were told to drink the entire contents of on container three times a day for one week. PTs were measured and INRs calculated on the day before grapefruit juice ingestion began (day 0) and a days 2, 6, and 8. Ten men (mean age, 66 years) were enrolled; one withdrew because of diarrhea. Compliance in consuming the juice was reported to range from 85.7% to 100% among patients. There was no significant difference among PT or INR values over the course of the study in any of the nine subjects. Ingestion of grapefruit juice prepared from frozen concentrate did not change PTs in patients treated with warfarin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9706183     DOI: 10.1093/ajhp/55.15.1581

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Stereoselective interaction of manidipine and grapefruit juice: a new twist on an old tale.

Authors:  Brian Tomlinson; Moses S S Chow
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

2.  Interactions of grapefruit juice and cardiovascular medications: A potential risk of toxicity.

Authors:  Gareth E Lim; Timao Li; Harpal S Buttar
Journal:  Exp Clin Cardiol       Date:  2003

Review 3.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

Review 4.  Grapefruit-drug interactions.

Authors:  Kay Seden; Laura Dickinson; Saye Khoo; David Back
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

5.  Absence of pharmacokinetic and pharmacodynamic interactions between almorexant and warfarin in healthy subjects.

Authors:  Jasper Dingemanse; Petra Hoever
Journal:  Drugs R D       Date:  2013-06

6.  Elevated international normalized ratio with the consumption of grapefruit and use of warfarin.

Authors:  Andrew B Bodiford; Fred O Kessler; Joli D Fermo; Kelly R Ragucci
Journal:  SAGE Open Med Case Rep       Date:  2013-11-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.